Diagnosis-specific graded prognostic assessment score is valid in patients with brain metastases treated in routine clinical practice in two European countries

Medical Science Monitor

Volumn 18, Issue 7, 2012, Pages

  Nieder, Carsten ^a,b   Andratschke, Nicolaus H ^c   Geinitz, Hans ^d   Grosu, Anca L ^e  

^a NORDLAND HOSPITAL   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

^c ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Brain metastases; Prognosis; Prognostic score; Radiosurgery; Radiotherapy

Indexed keywords

ADULT; ARTICLE; BRAIN METASTASIS; BREAST CANCER; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; FEMALE; HUMAN; KIDNEY CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MELANOMA; RETROSPECTIVE STUDY;

EID: 84863799816     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.883213     Document Type: Article

References (20)

1. Sperduto PW, Kased N, Roberge D et al: Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases. J Clin Oncol, 2012; 30: 419-25
2. Sperduto PW, Berkey B, Gaspar LE et al: A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database. Int J Radiat Oncol Biol Phys, 2008;70: 510-14
3. Gaspar L, Scott C, Rotman M et al: Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys, 1997; 37: 745-51
4. Lorenzoni J, Devriendt D, Massager N et al: Radiosurgery for treatment of brain metastases: Estimation of patient eligibility using three stratification systems. Int J Radiat Oncol Biol Phys, 2004; 60: 218-24
5. Nieder C, Pawinski A, Molls M: Prediction of short survival in patients with brain metastases based on three different scores: a role for 'triplenegative' status? Clin Oncol (R Coll Radiol), 2010; 22: 65-69
6. Nieder C, Bremnes RM, Andratschke NH: Prognostic scores in patients with brain metastases from non-small cell lung cancer. J Thorac Oncol, 2009; 4: 1337-41
7. Eigentler TK, Figl A, Krex D et al: Dermatologic Cooperative Oncology Group and the National Interdisciplinary Working Group on Melanoma. Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma. Cancer, 2011; 117: 1697-703
8. Lagerwaard FJ, Levendag PC, Nowak PJ et al: Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. Int J Radiat Oncol Biol Phys, 1999; 43: 795-803
9. Nieder C, Mehta MP: Prognostic indices for brain metastases usefulness and challenges. Radiat Oncol, 2009; 4: 10
10. Patchell RA, Tibbs PA, Walsh JW et al: A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med, 1990; 322: 494-500
11. Andrews DW, Scott CB, Sperduto PW et al: Whole brain radiation therapy with and without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomized trial. Lancet, 2004; 363: 1665-72
12. Rades D, Kueter JD, Hornung D et al: Comparison of stereotactic radiosurgery (SRS) alone and whole brain radiotherapy (WBRT) plus a stereotactic boost (WBRT+SRS) for one to three brain metastases. Strahlenther Onkol, 2008; 184: 655-62
13. Rades D, Kieckebusch S, Haatanen T et al: Surgical resection followed by whole brain radiotherapy versus whole brain radiotherapy alone for single brain metastasis. Int J Radiat Oncol Biol Phys, 2008; 70: 1319-24
14. Kalkanis SN, Kondziolka D, Gaspar LE et al: The role of surgical resection in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol, 2010; 96: 33-43
15. Linskey ME, Andrews DW, Asher AL et al: The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol, 2010; 96: 45-68. Erratum in: J Neurooncol, 2010; 96: 69-70
16. Jenkinson MD, Haylock B, Shenoy A et al: Management of cerebral metastasis: evidence-based approach for surgery, stereotactic radiosurgery and radiotherapy. Eur J Cancer, 2011; 47: 649-55
17. Suh JH, Videtic GM, Aref AM et al: ACR Appropriateness Criteria: single brain metastasis. Curr Probl Cancer, 2010; 34: 162-74
18. Roehrig S, Wein A, Albrecht H et al: Palliative first-line treatment with weekly high-dose 5-fluorouracil as 24h-infusion and gemcitabine in metastatic pancreatic cancer (UICC IV). Med Sci Monit, 2010; 16(3): CR124-31
19. Boxberger F, Albrecht H, Konturek PC et al: Neoadjuvant treatment with weekly high-dose 5-fluorouracil as a 24h-infusion, folinic acid and biweekly oxaliplatin in patients with primary resectable liver metastases of colorectal cancer: long-term results of a phase II trial. Med Sci Monit, 2010; 16(2): CR49-55
20. Gottwald L, Pluta P, Piekarski J et al: Long-term survival of endometrioid endometrial cancer patients. Arch Med Sci, 2010; 6: 937-44CR